Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Short Selling Data Report : Apr,17 54.79%
http://otcshortreport.com/index.php?index=EPXY&action=view#.VLfIlp-1L5L
Historical Short Selling Data For EPXY
Date VolShorted ShortVol RegularVol
Apr 17 54.79% 568,344 1,037,244
EPOXY INC - Short Selling Data Report
http://otcshortreport.com/index.php?index=EPXY&action=view#.VLfIlp-1L5L
Historical Short Selling Data For EPXY
Date VolShorted ShortVol RegularVol
Apr 16 32.24% 1,223,151 3,794,109
Annual Report (10-k)
Date : 04/15/2015 @ 2:48PM
Source : Edgar (US Regulatory)
Stock : Epoxy, Inc. (QB) (EPXY)
http://ih.advfn.com/p.php?pid=nmona&article=66433434&symbol=EPXY
As of April 10, 2015, there were 182,671,770 shares of common stock, par value $0.00001 per share, of the registrant outstanding.
EPOXY INC - Short Selling Data Report
http://otcshortreport.com/index.php?index=EPXY&action=view#.VLfIlp-1L5L
Historical Short Selling Data For EPXY
Date VolShorted ShortVol RegularVol
Apr 07 41.34% 102,607 248,200
Annual Report Will Be Submitted Late (nt 10-k)
http://ih.advfn.com/p.php?pid=nmona&article=66130977&symbol=EPXY
...Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
Yes [X] No [ ]
During the fiscal year ended December 31, 2013 the Company concluded an agreement to purchase Couponz, Inc. (“Couponz”), a Company incorporated in the State of Nevada whereby we acquired 100% of the ownership of Couponz, Inc. in exchange for the issuance of preferred stock of the Company and cash. Upon completion of the transaction, Couponz, Inc. became a wholly owned subsidiary of the Company. The business combination was accounted for as a reverse acquisition and recapitalization using accounting principles applicable to reverse acquisitions whereby the financial statements subsequent to the date of the transaction are presented as a continuation of Couponz. Under reverse acquisition accounting Couponz (subsidiary) is treated as the accounting parent (acquirer) and the Company (parent) is treated as the accounting subsidiary (acquiree). As a result of this transaction, the comparative figures reported in the current Form 10K for the year ended December 31, 2014 and 2013 are that of the acquired company. The Company expects its operational results to reflect an increase in net revenues period over period, offset by a substantial increase in professional fees and general administrative expenses as well as salaries and other consulting expense, with a decrease to software development costs. In addition during the most recently completed fiscal year the Company completed certain financing agreements to raise gross proceeds of $225,000 which amount will be offset with agent fees and other associated costs, with no comparative expenditure during the prior comparative period. In addition, during the current period the Company renegotiated certain convertible notes and retired certain debt by the issuance of securities. The Company expects to report a net operating loss of approximately $347,000 for the year ended December 31, 2014, as compared to a net operating loss of $118,157 in the same period ended December 31, 2013; and to report a net loss of approximately $1,948,000 for the year ended December 31, 2014, as compared to a net loss of $125,233 in the prior comparative period
Loyalty Cards for Botox? Why not?!
March 27, 2015 / By Dave Gasparine
http://epoxyapp.com/loyalty-cards-for-botox-why-not/
If you thought loyalty cards were only good for things like smoothies and sandwiches, think again. Nowak Aesthetics, based in San Diego, California, is getting very creative with its Epoxy virtual loyalty card program.
Nowak Aesthetics offers a suite of minimally invasive outpatient procedures including body sculpting, laser and vein treatments, tummy tuck alternatives, and many forms of facial rejuvenation “injectables,” including, of course – Botox.
The repetitive nature of injectable procedures like Botox (results typically last between 3 and 6 months) makes them ideal services for an Epoxy loyalty program.
And get this – Nowak is upping the ante by offering patients an extra virtual punch if they book their next appointment before they leave. Genius! Nowak also offers a separate Epoxy loyalty card for the array of skin care products they sell.
Nowak also takes advantage of the Epoxy referral program
Aside from the successful virtual loyalty program, Nowak has also implemented the Epoxy App’s built-in referral program.
How it works: when a Nowak customer recommends Nowak to a friend, not only does the friend get $50 off their first treatment, the customer gets a $50 credit on their account! This program has been hugely successful for the business.
But how are they getting so many customers on board?
Here’s one way. At a recent in-office event, featuring discounts on everything from skin care packages to products, Nowak used the Epoxy App as an integral part of the event marketing mix.
Customers were enticed to pre-register, and when they did, they were asked to download the Epoxy App which would then serve as their actual admission to the event. All customers had to do was flash their smartphone. This was Nowak’s way to ensure that new (and existing) customers get comfortable using the Epoxy App right off the bat. As an added bonus, no one had to print out paper tickets to attend!
Get creative with your own Epoxy programs
Nowak Aesthetics is a great example of the capabilities the Epoxy App holds for business owners everywhere. Whether for products or services, our loyalty program can be a huge asset. And customers love not having to cart around that stack of paper punch cards and plastic swipe cards.
As for the referral program, any business on the Epoxy App can take advantage of this as well. As the business owner, you determine what the reward structure will be – you can choose a monetary credit amount or you can offer a small product or service as the incentive.
The point is, Epoxy has countless tools you can start using today to attract and keep loyal customers. At the end of the day, that’s what every successful small business wants, and it’s what Nowak Aesthetics has been doing from day one.
Find out how your business can unlock a whole new world of marketing and customer loyalty possibilities with the Epoxy App.
EPOXY INC - Short Selling Data Report
http://otcshortreport.com/index.php?index=EPXY&action=view#.VLfIlp-1L5L
IR: info@epoxyapp.com
http://epoxyapp.com/about/investor-relations/
Loyalty Cards & Referral Program - Nowak Aesthetics
http://drnowak.com/loyalty-cards-referral-program/
BID @911 - NEWS in the pipeline??
There is a Reason They Flock to EPOXY Inc (OTCMKTS:EPXY)
By Daniel McCarthy on March 12, 2015
http://www.microcapdaily.com/there-is-a-reason-they-flock-to-epoxy-inc-otcmktsepxy/19550/
EPOXY Inc (OTCMKTS:EPXY) is the kind of stock we like to report on around here; the stock has seen a spectacular rise over the past year from well under a penny to a recent high of $0.18 a share.
Every time EPXY runs it trades huge volume and goes into beast mode and then it consolidates, forms a new base and trades in a channel on light volume never really giving that much back. The stock has shown excellent support at every new price level achieved on the way up.
EPOXY Inc (OTCMKTS:EPXY) is a smart phone app that lets consumers keep track of their Rewards, Gift cards and Digital Punch cards safely on their phone. It lets business’s market in a whole new way. Captioned ”the only gift & loyalty card app built for store owners by store owners” it has a number of cool features which a business can activate on the app.
The Consumer can just download the free mobile app and now has access to all their Digital Punch cards right on their phone where they are safe and secure and well organized. This is significant; a lot of people, Myself included are disorganized and constantly lose or ruin physical Punch cards.
The latest feature is Gift Cards which lets consumers find the business they want to buy a gift card for, purchase it online and send it to their friends from the comfort of their own home rather than drive to a physical store.
EPOXY has been very successful in partnering with business’s for the app, first locally and then with a fast growing number of national chain services such as Dairy Queen, Empowered Hypnosis Centers, Optic Gallery Family Eye Centers and Carlos and Charlie’s part of ‘Groupo Anderson’ chain of restaurants and many more. Initially focused on Restaurants they have successfully expanded the app into different genres of business.
According to CEO David Gasparine the plan for 2015 is to increase diversification, targeting more professional services such as Lawyers, Doctors, Technology such as 3D printing shops and mobile phone retailers and of course a full launch into the areas they are currently beta testing in.
The Company doesn’t really put out much news; on January 26 they said they successfully expanded to New York City with the addition of Empowered Hypnosis Centers. Epoxy has also commenced beta testing in Europe.
EPOXY has begun testing in The UAE and Germany due to repeated requests and overwhelming interest from the areas. The Company has also been targeting professional business services such as Optometry, Health and Wellness and Technology firms to add to its ever-growing portfolio of clients.
At the time, EPOXY CEO David Gasparine said “We are very pleased to have grown our business to New York with the addition of Empowered Hypnosis Centers to the Epoxy family. Epoxy has also been Beta testing overseas, in particular the UAE and Germany. We are working in these areas to test the demographics and look to ensure a transition that goes as smooth as possible. We are excited to test the international space as well and make Epoxy as effective as possible.”
Currently trading at a $20 million market valuation EPXY has little assets or revenues and rising short term debt. But EPXOY has got runner in its blood and this run is nothing short of spectacular. The Company has an exciting new app that’s getting picked up by business’s across a broad spectrum of industries. EPXY also has a loyal shareholder base both in the US and in Europe that supports the stock and swears it goes higher. There is also a limited float here and what there is seems to be tightly controlled. We will be updating on EPXY when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with EPXY.
Short Selling Data For EPXY (March 09, 2015)
Date VolShorted ShortVol RegularVol
Mar 09 21.13% 950,565 4,499,233
hotStocked by Georgi Kamburov
March 10, 2015
http://www.hotstocked.com/article/89479/epoxy-inc-otcmkts-epxy-barely-avoids-another-red.html
Business Summary
http://finance.yahoo.com/q/pr?s=RGDX
Response Genetics, Inc., a life science company, is engaged in the research, development, marketing, and sale of pharmacogenomic tests for use in the treatment of cancer primarily in the United States, Asia, and Europe.
It develops genetic tests that measure predictive factors for therapy response in tumor tissue samples.
The company offers tests for non-small cell lung cancer, gastric and gastroesophageal cancer, melanoma and thyroid cancer, and breast cancer patients? tumor tissue specimens through its ResponseDX: Lung, ResponseDX: Colon, ResponseDX: Gastric, ResponseDX: Melanoma, ResponseDX: Thyroid, ResponseDX: Breast, and ResponseDX: and Tissue of Origin test suites.
It also provides HER2 mutation detection, cKIT mutation detection, MET gene amplification, and UGT1A1 SNP tests, including ROS1 FISH, ROS1 RT-PCR, c-MET, HER2 FISH, and VEGFR2.
In addition, the company focuses on the development of various diagnostic tests for predicting therapy response and determining the diagnosis and prognosis of solid tumors in cancer patients.
It serves community based oncologists, pathologists, physician offices, and hospitals, as well as pharmaceutical companies and cancer care centers through its sales force.
Atossa Genetics Announces That Its Subsidiary The National Reference Laboratory for Breast Health Has Received Accreditation From the College of American Pathologists
http://finance.yahoo.com/news/atossa-genetics-announces-subsidiary-national-130000054.html
SEATTLE, WA--(Marketwired - Feb 27, 2015) - Atossa Genetics Inc. (NASDAQ: ATOS), the Breast Care Company, announced today that its subsidiary, The National Reference Laboratory for Breast Health (the NRLBH), has received accreditation from the College of American Pathologists (CAP), which is awarded to facilities that meet the highest standards of excellence in quality laboratory practices. The NRLBH is also certified by the Centers for Medicare and Medicaid Services' Clinical Laboratory Improvements Amendment (CLIA) and holds various state licenses.
The NRLBH was assigned CAP number 8016287. The NRLBH, located in Seattle, Washington, currently provides pharmacogenomics testing and cytology testing of nipple aspirate fluid.
According to the College of American Pathologists, "The CAP Laboratory Accreditation Program is an internationally recognized program and the only one of its kind that utilizes teams of practicing laboratory professionals as inspectors. Designed to go well beyond regulatory compliance, the program helps laboratories achieve the highest standards of excellence to positively impact patient care. The program also covers a complete array of disciplines and testing procedures. Because of its comprehensive nature, CAP accreditation can help achieve a consistently high level of service throughout an institution or healthcare system. The Centers for Medicare and Medicaid Services (CMS) has granted the CAP Laboratory Accreditation Program deeming authority. It is also recognized by the Joint Commission, and can be used to meet many state certification requirements."
Dr. Steven Quay, Chairman, CEO & President of Atossa Genetics, said, "We are extremely proud to receive CAP accreditation. This national recognition reaffirms NRLBH's commitment to providing the highest quality laboratory services and reliable testing results to its clients, and is reflective of our focus on helping healthcare providers take better care of patients and improve their medical conditions."
About Atossa Genetics
Atossa Genetics Inc. is focused on improving breast health through the development of laboratory services, medical devices and therapeutics. The laboratory services are being developed by its subsidiary, the NRLBH. The laboratory services and the Company's medical devices are being developed so they can be used as companions to therapeutics to treat various breast health conditions. For more information, please visit www.atossagenetics.com.
Forward-Looking Statements
Forward-looking statements in this press release are subject to risks and uncertainties that may cause actual results to differ materially from the anticipated or estimated future results, including the risks and uncertainties associated with actions by the FDA, the outcome or timing of regulatory approvals needed by Atossa to sell its products, responses to regulatory matters, Atossa's ability to continue to manufacture and sell its products, recalls of products, the safety and efficacy of Atossa's products and services, performance of distributors, whether Atossa can launch in the United States and foreign markets the additional tests, devices and therapeutics in its pipeline in a timely and cost effective manner, and other risks detailed from time to time in Atossa's filings with the Securities and Exchange Commission, including without limitation its periodic reports on Form 10-K and 10-Q, each as amended and supplemented from time to time
AH: 0.72 (at this time)
IMO $0.8 - $0.9 eod...
$2.59 new52wkh
knock, knock $2.50
ATOS
Henry Schein Medical to Offer Atossa Genetics' FullCYTE Breast Aspirator
http://finance.yahoo.com/news/henry-schein-medical-offer-atossa-130000479.html
SEATTLE, WA--(Marketwired - Feb 26, 2015)
\\\\\\\\\\\\\\\
Atossa Genetics Signs National Distribution Agreement With Thermo Fisher Scientific for FullCYTE Breast Aspirator
http://www.marketwired.com/press-release/atossa-genetics-signs-national-distribution-agreement-with-thermo-fisher-scientific-nasdaq-atos-1989768.htm
SEATTLE, WA--(Marketwired - Feb 9, 2015)
\\\\\\\\\\\\\\\\
Henry Schein Medical to Offer Atossa Genetics' FullCYTE Breast Aspirator
Marketwired
Atossa Genetics Inc
http://finance.yahoo.com/news/henry-schein-medical-offer-atossa-130000479.html
SEATTLE, WA--(Marketwired - Feb 26, 2015) - Atossa Genetics Inc. (NASDAQ: ATOS), the Breast Care Company, announced today that Henry Schein Medical, the U.S. Medical business of Henry Schein, Inc. (NASDAQ: HSIC), will offer its customers the FullCYTE Breast Aspirator. The Atossa FullCYTE Breast Aspirator is used by OB/GYNs, primary care physicians and women's clinics to collect fluid from breasts for subsequent cytological evaluation.
Dr. Steven C. Quay, Chairman, President & CEO of Atossa Genetics, commented, "Working with Henry Schein is an important step forward in making the FullCYTE Breast Aspirator available nationwide. Henry Schein is an industry leader and its multi-channel sales organization allows for expanded reach into multiple market segments within health care for our device. We are thrilled to work with a company such as Henry Schein and believe our arrangement will contribute positively to our upcoming nationwide launch."
About Atossa Genetics
Atossa Genetics Inc. is focused on improving breast health through the development of laboratory services, medical devices and therapeutics. The laboratory services are being developed by its subsidiary, The National Reference Laboratory for Breast Health, Inc. The laboratory services and the Company's medical devices are being developed so they can be used as companions to therapeutics to treat various breast health conditions. For more information, please visit www.atossagenetics.com.
About Henry Schein, Inc.
Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500® Company and a member of the NASDAQ 100® Index, Henry Schein employs more than 17,500 Team Schein Members and serves more than 1 million customers.
The Company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 96,000 branded products and Henry Schein private-brand products in stock, as well as more than 110,000 additional products available as special-order items. The Company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services.
Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 28 countries. The Company's sales reached a record $10.4 billion in 2014, and have grown at a compound annual rate of approximately 16% since Henry Schein became a public company in 1995. For more information, visit the Henry Schein website at www.henryschein.com.
Forward-Looking Statements
Forward-looking statements in this press release are subject to risks and uncertainties that may cause actual results to differ materially from the anticipated or estimated future results, including the risks and uncertainties associated with actions by the FDA, the outcome or timing of regulatory approvals needed by Atossa to sell its products, responses to regulatory matters, Atossa's ability to continue to manufacture and sell its products, recalls of products, the safety and efficacy of Atossa's products and services, performance of distributors, whether Atossa can launch in the United States and foreign markets the additional tests, devices and therapeutics in its pipeline in a timely and cost effective manner, and other risks detailed from time to time in Atossa's filings with the Securities and Exchange Commission, including without limitation its periodic reports on Form 10-K and 10-Q, each as amended and supplemented from time to time.
today EPXY on OTC with status HTB (hard to borrow)
maybe Chicago next?!
https://www.swarmapp.com/c/1nuZFMaY36l
KW Las Vegas - maybe next one?!!
IBOX (Epoxy Intro @ ihub) updated!
http://investorshub.advfn.com/boards/show_ibox.aspx?boardid=13309
Epoxy, Inc. has Retained the Services of Scherf Corporation to Head its Public Relations
http://www.eteligis.com/ViewSubmission.aspx?submissionRequest=28074
LAS VEGAS, NV, United States, via ETELIGIS INC., 02/19/2015 - - Epoxy, Inc. (OTCQB: EPXY) (“Epoxy Inc.” or the “Company”) an emerging mobile application company, today announces, The Company has retained the services of Scherf Corporation with its Founder Dietmar Scherf in the capacity as Epoxy's Senior Public Relations Manager, in support of The Company's enhanced marketing initiative. Scherf Corporation is a corporate consulting and public relations firm which is headed by Dietmar Scherf who has over 30 years of experience in communications, marketing and public relations in the investment industry and in related fields.
Dietmar Scherf of Scherf Corporation quote, "Our primary objective is to strategically expand the name recognition of a brand to make it stand out in the marketplace as a household name. To achieve this goal, our approach is a bit different from the norm as it is much more than just about a campaign, a splash or a buzz here and there. Instead, we strategically create a phenomena with a global impact of brand awareness resulting in an increased momentum for a company's growth for years to come. That's what we're specializing in. To utilize our approach and expertise for the utmost impact and lasting results we need to be very selective about the quality of products and companies that we get involved in. We're very excited that in EpoxyApp, the product, with its company Epoxy, Inc., we found that rare gem, that needle in the haystack, which exceeds all of our most stringent criteria."
David Gasparine CEO of Epoxy adds; "As a startup company we're thrilled to have retained Scherf Corporation with Dietmar Scherf on board. With an established and exceptional track record over many years, we hope that Scherf's eloquent PR approach with its proven methodology and techniques will provide strong support to strategically grow our brand on a national and international basis."
About Scherf Corporation:
Scherf Corporation is not just another PR firm for hire. Instead, every client we take on is carefully selected and must pass multiple tests regarding the quality of a company's products/services and the company itself to provide a solid foundation for our convictions. At Scherf we believe that results and success cannot be vague, but must be targeted and measurable. Our strategies are a proven catalyst for growth. It is our objective to exceed a client's expectations, which is accomplished by our work ethic as our endeavors are like a sport to us. With our extensive expertise we're able to effectively put our heart and soul to work to generate exceptional results for our clients.
Founder, Dietmar Scherf, has more than 30 years of experience as a communications, marketing and PR professional in the financial and investment industry as well as in related fields. In 1989, Mr. Scherf was the founder of Europe's first discount brokerage firm in Vienna, Austria. With its unique approach the firm revolutionized the securities industry in that region. Over the years, he has authored a number of bestselling books and as a corporate consultant his advice is often sought after by top-level executives of leading companies.
About Epoxy Inc.:
Epoxy, Inc. is the developer of the Epoxy app, an application or "app" for iPhone iOS and Android operating systems. Epoxy is an innovative smart phone application designed and created to conveniently connect business owners and consumers in order to ease marketing frustrations. The mobile app gives loyal customers the ease of keeping track of rewards and punch cards and the recently added gift card function all in one place while also giving opportunities to review and share businesses with friends. In turn, Epoxy provides businesses the ability to reward customers, share offers, and deliver information about special events with their customers and offer card-less gift cards right on your smart phone. Epoxy designers are dedicated to providing a superior and easy-to-use product for business owners to reward loyal customers.
Website: http://epoxyapp.com/about/investor-relations/
Facebook: https://www.facebook.com/groups/566466450082241/
Forward-Looking Statement:
This release contains forward-looking statements that reflect Epoxy Inc., and Couponz, Inc., and Scherf corporation plans and expectations. In this press release and related comments by Company management, words like "expect," "anticipate," "estimate," "forecast," "objective," "plan," "goal" and similar expressions are used to identify forward-looking statements, representing management's current judgment and expectations about possible future events. Management believes these forward-looking statements and the judgments upon which they are based to be reasonable, but they are not guarantees of future performance and involve numerous known and unknown risks, uncertainties and other factors that may cause the Company's actual results, performance, achievements or financial position to be materially different from any future results, performance, achievements or financial position expressed or implied by these forward-looking statements.
CONTACT:
Dave Gasparine
Email: PR@epoxyapp.com
...not 55%, but 43% shorted!
http://otcshortreport.com/index.php?index=EPXY&action=view#.VOgYy5-1L5L
Historical Short Selling Data For EPXY
Date VolShorted ShortVol RegularVol
Feb 20 43.36% 141,310 325,882
EPOXY INC - Short Selling Data Report
http://otcshortreport.com/index.php?index=EPXY&action=view#.VLfIlp-1L5L
...imo, today ~ 55%?!!
Historical Short Selling Data For EPXY
Date VolShorted ShortVol RegularVol
Feb 19 30.38% 375,314 1,235,208
Feb 18 43.62% 808,515 1,853,356
Feb 17 41.53% 341,303 821,878
Feb 13 23.51% 30,379 129,222
...as an european (german) Epoxy Investor
your questions about the volume in GERMANY will better be answered there:
https://m.facebook.com/home.php?refsrc=https%3A%2F%2Fm.facebook.com%2Fgroups%2F1390752811234031%3Fref%3Dbookmark&refid=8&_rdr#!/groups/859609014059848?ref=bookmark
Atossa Genetics to Exhibit at Two Medical Conferences: 8th Annual International Symposium on the Breast February 19-21, 2015, and The National Consortium of Breast Centers Meeting March 14-18, 2015
http://finance.yahoo.com/news/atossa-genetics-exhibit-two-medical-130000259.html
SEATTLE, WA--(Marketwired - Feb 17, 2015) - Atossa Genetics Inc. (NASDAQ: ATOS), the Breast Care Company, will exhibit at two upcoming medical conferences:
The 8th Annual International Symposium on the Breast: Using Next Generation Science to Understand the Normal Breast and the Development of Breast Cancer. This conference will be held in Santa Monica, California February 19-21, 2015.
The National Consortium of Breast Centers Meeting to be held March 14-18, 2015 in Las Vegas, Nevada. This conference will include the FullCYTE Breast Aspirator device, which is used to collect nipple aspirate fluid for cytological analysis at a laboratory.
Dr. Steven Quay, Chairman, CEO & President of Atossa Genetics, said, "The 8th Annual International Symposium on the Breast is a key meeting as leaders from many regions in the field of breast health will come together to discuss breast health innovations regarding procedures and the latest developments." Dr. Quay continued, "The National Consortium of Breast Centers Meeting provides an important opportunity to meet with clinicians on breast health products, and we are looking forward to participating."
About Atossa Genetics
Atossa Genetics Inc. is focused on improving breast health through the development of laboratory services, medical devices and therapeutics. The laboratory services are being developed by its subsidiary, The National Reference Laboratory for Breast Health, Inc. The laboratory services and the Company's medical devices are being developed so they can be used as companions to therapeutics to treat various breast health conditions. For more information, please visit www.atossagenetics.com.
Forward-Looking Statements
Forward-looking statements in this press release are subject to risks and uncertainties that may cause actual results to differ materially from the anticipated or estimated future results, including the risks and uncertainties associated with actions by the FDA, the outcome or timing of regulatory approvals needed by Atossa to sell its products, responses to regulatory matters, Atossa's ability to continue to manufacture and sell its products, recalls of products, the safety and efficacy of Atossa's products and services, performance of distributors, whether Atossa can launch in the United States and foreign markets the additional tests, devices and therapeutics in its pipeline in a timely and cost effective manner, and other risks detailed from time to time in Atossa's filings with the Securities and Exchange Commission, including without limitation its periodic reports on Form 10-K and 10-Q, each as amended and supplemented from time to time
The gift & loyalty card app the #franchise industry has been waiting for #IFA2015 get ready to learn about @EpoxyApp http://t.co/PsVwBGfWHN
The Epoxy App is ready to take on the franchising world, but is it ready for us! The team is making its first... http://t.co/3NdxqMggbA
Version 6.1.1 on itunes APP STORE
https://itunes.apple.com/us/app/epoxy/id418287288?l=en&mt=8
What's New in Version 6.1.1
-Added Google Maps
-Fixed Background Images
Updated: Feb 07, 2015
THE only LOYALTY & GIFT CARD APP built FOR STORE OWNERS BY STORE OWNERS.
Wondering why you need an app?
Watch our short video.